Acute panmyelosis with myelofibrosis

An entity distinct from acute megakaryoblastic leukemia

Attilio Orazi, Dennis P. O'Malley, Jiazhong Jiang, Gail Vance, Janice Thomas, Magdalena Czader, Wei Fang, Caroline An, Peter M. Banks

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The WHO criteria for diagnosing acute panmyelosis with myelofibrosis are somewhat distinct from those for acute megakaryoblastic leukemia. However, clinical and hematopathologic findings partially overlap. This has raised questions as to whether these are indeed separate, definable entities. To determine the potential importance of bone marrow biopsy supplemented by immunohistochemistry in distinguishing between these two conditions, we studied 17 bone marrow biopsies of well-characterized cases of acute panmyelosis with myelofibrosis (six cases) and acute megakaryoblastic leukemia (11 cases). We compared blast frequency, reticulin content, CD34 expression, and the degree of megakaryocytic differentiation of the blast cells in these two conditions. Our results demonstrate important differences. Acute panmyelosis with myelofibrosis is characterised by a multilineage myeloid proliferation with a less numerous population of blasts than acute megakaryoblastic leukemia (P<0.01). In the former condition, blasts are always positive with CD34, while in acute megakaryoblastic leukemia they express CD34 in 60% of the cases. The blasts in acute panmyelosis with myelofibrosis only rarely express megakaryocytic antigens. By contrast, acute megakaryoblastic leukemia has a significantly higher proportion of blasts expressing megakaryocytic antigens (P<0.01 with CD42b). Our results confirm that histology supplemented by immunohistochemistry permits the distinction of these conditions in routinely processed bone marrow biopsies.

Original languageEnglish
Pages (from-to)603-614
Number of pages12
JournalModern Pathology
Volume18
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Leukemia, Megakaryoblastic, Acute
Primary Myelofibrosis
Bone Marrow
Biopsy
Immunohistochemistry
Reticulin
Antigens
Cell Differentiation
Histology
Population

Keywords

  • Acute megakaryoblastic leukemia
  • Acute panmyelosis myelofibrosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Acute panmyelosis with myelofibrosis : An entity distinct from acute megakaryoblastic leukemia. / Orazi, Attilio; O'Malley, Dennis P.; Jiang, Jiazhong; Vance, Gail; Thomas, Janice; Czader, Magdalena; Fang, Wei; An, Caroline; Banks, Peter M.

In: Modern Pathology, Vol. 18, No. 5, 05.2005, p. 603-614.

Research output: Contribution to journalArticle

Orazi, Attilio ; O'Malley, Dennis P. ; Jiang, Jiazhong ; Vance, Gail ; Thomas, Janice ; Czader, Magdalena ; Fang, Wei ; An, Caroline ; Banks, Peter M. / Acute panmyelosis with myelofibrosis : An entity distinct from acute megakaryoblastic leukemia. In: Modern Pathology. 2005 ; Vol. 18, No. 5. pp. 603-614.
@article{957f9096482745b592217f2958af9546,
title = "Acute panmyelosis with myelofibrosis: An entity distinct from acute megakaryoblastic leukemia",
abstract = "The WHO criteria for diagnosing acute panmyelosis with myelofibrosis are somewhat distinct from those for acute megakaryoblastic leukemia. However, clinical and hematopathologic findings partially overlap. This has raised questions as to whether these are indeed separate, definable entities. To determine the potential importance of bone marrow biopsy supplemented by immunohistochemistry in distinguishing between these two conditions, we studied 17 bone marrow biopsies of well-characterized cases of acute panmyelosis with myelofibrosis (six cases) and acute megakaryoblastic leukemia (11 cases). We compared blast frequency, reticulin content, CD34 expression, and the degree of megakaryocytic differentiation of the blast cells in these two conditions. Our results demonstrate important differences. Acute panmyelosis with myelofibrosis is characterised by a multilineage myeloid proliferation with a less numerous population of blasts than acute megakaryoblastic leukemia (P<0.01). In the former condition, blasts are always positive with CD34, while in acute megakaryoblastic leukemia they express CD34 in 60{\%} of the cases. The blasts in acute panmyelosis with myelofibrosis only rarely express megakaryocytic antigens. By contrast, acute megakaryoblastic leukemia has a significantly higher proportion of blasts expressing megakaryocytic antigens (P<0.01 with CD42b). Our results confirm that histology supplemented by immunohistochemistry permits the distinction of these conditions in routinely processed bone marrow biopsies.",
keywords = "Acute megakaryoblastic leukemia, Acute panmyelosis myelofibrosis",
author = "Attilio Orazi and O'Malley, {Dennis P.} and Jiazhong Jiang and Gail Vance and Janice Thomas and Magdalena Czader and Wei Fang and Caroline An and Banks, {Peter M.}",
year = "2005",
month = "5",
doi = "10.1038/modpathol.3800348",
language = "English",
volume = "18",
pages = "603--614",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Acute panmyelosis with myelofibrosis

T2 - An entity distinct from acute megakaryoblastic leukemia

AU - Orazi, Attilio

AU - O'Malley, Dennis P.

AU - Jiang, Jiazhong

AU - Vance, Gail

AU - Thomas, Janice

AU - Czader, Magdalena

AU - Fang, Wei

AU - An, Caroline

AU - Banks, Peter M.

PY - 2005/5

Y1 - 2005/5

N2 - The WHO criteria for diagnosing acute panmyelosis with myelofibrosis are somewhat distinct from those for acute megakaryoblastic leukemia. However, clinical and hematopathologic findings partially overlap. This has raised questions as to whether these are indeed separate, definable entities. To determine the potential importance of bone marrow biopsy supplemented by immunohistochemistry in distinguishing between these two conditions, we studied 17 bone marrow biopsies of well-characterized cases of acute panmyelosis with myelofibrosis (six cases) and acute megakaryoblastic leukemia (11 cases). We compared blast frequency, reticulin content, CD34 expression, and the degree of megakaryocytic differentiation of the blast cells in these two conditions. Our results demonstrate important differences. Acute panmyelosis with myelofibrosis is characterised by a multilineage myeloid proliferation with a less numerous population of blasts than acute megakaryoblastic leukemia (P<0.01). In the former condition, blasts are always positive with CD34, while in acute megakaryoblastic leukemia they express CD34 in 60% of the cases. The blasts in acute panmyelosis with myelofibrosis only rarely express megakaryocytic antigens. By contrast, acute megakaryoblastic leukemia has a significantly higher proportion of blasts expressing megakaryocytic antigens (P<0.01 with CD42b). Our results confirm that histology supplemented by immunohistochemistry permits the distinction of these conditions in routinely processed bone marrow biopsies.

AB - The WHO criteria for diagnosing acute panmyelosis with myelofibrosis are somewhat distinct from those for acute megakaryoblastic leukemia. However, clinical and hematopathologic findings partially overlap. This has raised questions as to whether these are indeed separate, definable entities. To determine the potential importance of bone marrow biopsy supplemented by immunohistochemistry in distinguishing between these two conditions, we studied 17 bone marrow biopsies of well-characterized cases of acute panmyelosis with myelofibrosis (six cases) and acute megakaryoblastic leukemia (11 cases). We compared blast frequency, reticulin content, CD34 expression, and the degree of megakaryocytic differentiation of the blast cells in these two conditions. Our results demonstrate important differences. Acute panmyelosis with myelofibrosis is characterised by a multilineage myeloid proliferation with a less numerous population of blasts than acute megakaryoblastic leukemia (P<0.01). In the former condition, blasts are always positive with CD34, while in acute megakaryoblastic leukemia they express CD34 in 60% of the cases. The blasts in acute panmyelosis with myelofibrosis only rarely express megakaryocytic antigens. By contrast, acute megakaryoblastic leukemia has a significantly higher proportion of blasts expressing megakaryocytic antigens (P<0.01 with CD42b). Our results confirm that histology supplemented by immunohistochemistry permits the distinction of these conditions in routinely processed bone marrow biopsies.

KW - Acute megakaryoblastic leukemia

KW - Acute panmyelosis myelofibrosis

UR - http://www.scopus.com/inward/record.url?scp=18744384687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744384687&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800348

DO - 10.1038/modpathol.3800348

M3 - Article

VL - 18

SP - 603

EP - 614

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -